These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10052907)

  • 1. Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase.
    Suling WJ; Reynolds RC; Barrow EW; Wilson LN; Piper JR; Barrow WW
    J Antimicrob Chemother; 1998 Dec; 42(6):811-5. PubMed ID: 10052907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
    da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
    J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.
    Suling WJ; Seitz LE; Pathak V; Westbrook L; Barrow EW; Zywno-Van-Ginkel S; Reynolds RC; Piper JR; Barrow WW
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2784-93. PubMed ID: 10991861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro.
    Suling WJ; Maddry JA
    J Antimicrob Chemother; 2001 Apr; 47(4):451-4. PubMed ID: 11266419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of clinical isolates of Mycobacterium avium and M. intracellulare to folate antagonists.
    Raszka WV; Skillman LP; McEvoy PL
    Diagn Microbiol Infect Dis; 1994 Mar; 18(3):201-4. PubMed ID: 7924214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.
    El-Hamamsy MH; Smith AW; Thompson AS; Threadgill MD
    Bioorg Med Chem; 2007 Jul; 15(13):4552-76. PubMed ID: 17451962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents.
    Tawari NR; Bag S; Raju A; Lele AC; Bairwa R; Ray MK; Rajan MG; Nawale LU; Sarkar D; Degani MS
    Future Med Chem; 2015; 7(8):979-88. PubMed ID: 26062396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antifolate inhibitors for Mycobacterium avium.
    Barrow EW; Suling WJ; Seitz LE; Reynolds RC; Barrow WW
    Med Chem; 2006 Sep; 2(5):505-10. PubMed ID: 17017990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase.
    Debnath AK
    J Med Chem; 2002 Jan; 45(1):41-53. PubMed ID: 11754578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.
    Forsch RA; Queener SF; Rosowsky A
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1811-5. PubMed ID: 15026078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans.
    Dhople AM
    J Antimicrob Chemother; 2001 Jan; 47(1):93-6. PubMed ID: 11152437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex.
    Meyer SC; Majumder SK; Cynamon MH
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1862-3. PubMed ID: 7486934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex.
    Shoen CM; Choromanska O; Reynolds RC; Piper JR; Johnson CA; Cynamon MH
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3315-6. PubMed ID: 9835537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding mode analysis of 2,4-diamino-5-methyl-5-deaza-6-substituted pteridines with Mycobacterium tuberculosis and human dihydrofolate reductases.
    da Cunha EF; Ramalho TC; Reynolds RC
    J Biomol Struct Dyn; 2008 Feb; 25(4):377-85. PubMed ID: 18092832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro antimicrobial susceptibilities of Mycobacterium avium-M. intracellulare strains from patients with acquired immunodeficiency syndrome (AIDS), patients without AIDS, and animal sources.
    Byrne SK; Geddes GL; Isaac-Renton JL; Black WA
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1390-2. PubMed ID: 2386370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
    Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.